Skip to main content
. 2015 Dec 21;16(1):45–52. doi: 10.1007/s40268-015-0114-8

Fig. 3.

Fig. 3

Alisertib a AUCinf and b C max in individual patients following single-dose administration of alisertib ECT 50 mg under fed or fasted conditions. *The terminal phase of the alisertib plasma concentration–time profile was not sufficiently defined in three patients. AUC inf area under the plasma concentration–time profile from time zero to infinity, C max maximum plasma concentration, ECT enteric-coated tablet